JP2021522262A5 - - Google Patents
Info
- Publication number
- JP2021522262A5 JP2021522262A5 JP2020560186A JP2020560186A JP2021522262A5 JP 2021522262 A5 JP2021522262 A5 JP 2021522262A5 JP 2020560186 A JP2020560186 A JP 2020560186A JP 2020560186 A JP2020560186 A JP 2020560186A JP 2021522262 A5 JP2021522262 A5 JP 2021522262A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- group
- heteroaryl
- alkenyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666312P | 2018-05-03 | 2018-05-03 | |
| US62/666,312 | 2018-05-03 | ||
| PCT/US2019/030526 WO2019213470A1 (en) | 2018-05-03 | 2019-05-03 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (rorϒ) and pharmaceutical uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021522262A JP2021522262A (ja) | 2021-08-30 |
| JP2021522262A5 true JP2021522262A5 (https=) | 2022-05-12 |
| JPWO2019213470A5 JPWO2019213470A5 (https=) | 2022-05-12 |
| JP7351851B2 JP7351851B2 (ja) | 2023-09-27 |
Family
ID=68386171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560186A Active JP7351851B2 (ja) | 2018-05-03 | 2019-05-03 | レチノイド関連オルファン受容体ガンマ（ＲＯＲγ）のモジュレーターとしてのベンジイミダゾール誘導体およびそれらの医薬品用途 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11512055B2 (https=) |
| EP (1) | EP3781161B1 (https=) |
| JP (1) | JP7351851B2 (https=) |
| KR (1) | KR102709804B1 (https=) |
| CN (2) | CN116514722A (https=) |
| AU (1) | AU2019262169B2 (https=) |
| BR (1) | BR112020021967A2 (https=) |
| CA (1) | CA3097519A1 (https=) |
| ES (1) | ES2949366T3 (https=) |
| HR (1) | HRP20230643T1 (https=) |
| HU (1) | HUE062273T2 (https=) |
| MX (1) | MX2020011405A (https=) |
| MY (1) | MY208400A (https=) |
| PL (1) | PL3781161T3 (https=) |
| RS (1) | RS64348B1 (https=) |
| SM (1) | SMT202300212T1 (https=) |
| TW (1) | TWI818985B (https=) |
| UA (1) | UA128161C2 (https=) |
| WO (1) | WO2019213470A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY208400A (en) * | 2018-05-03 | 2025-05-07 | Shanghai hengrui pharmaceutical co ltd | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (ror) and pharmaceutical uses thereof |
| US20220411380A1 (en) * | 2019-10-31 | 2022-12-29 | Jiangsu Hengrui Medicine Co., Ltd. | ACID ADDITION SALT OF RORy REGULATOR |
| CN112745268B (zh) * | 2019-10-31 | 2022-09-16 | 江苏恒瑞医药股份有限公司 | 苯并咪唑衍生物的晶型及制备方法 |
| TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
| TW202136237A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
| CN111269126B (zh) * | 2020-03-12 | 2023-04-07 | 北京理工大学重庆创新中心 | 一种熔铸载体1,2-二氟-4,5-二硝基苯的制备方法 |
| CA3179686A1 (en) * | 2020-04-07 | 2021-10-14 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| TW202146381A (zh) * | 2020-05-15 | 2021-12-16 | 大陸商上海輝启生物醫藥科技有限公司 | 可用作RORγ調節劑的聯芳基類化合物 |
| WO2022245067A1 (ko) * | 2021-05-17 | 2022-11-24 | 서울대학교 산학협력단 | RORα의 활성자 JC1-40을 포함하는 근감소증 예방, 개선, 또는 치료를 위한 약학적 조성물 |
| CN121045325A (zh) * | 2024-05-31 | 2025-12-02 | 中国科学院广州生物医药与健康研究院 | 磺酰胺基乙酰胺类化合物及其制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075991A (en) * | 1960-01-20 | 1963-01-29 | Dow Chemical Co | Benzimidazolylalkylbenzene-sulfonamide compounds |
| DE60023920T2 (de) * | 1999-08-27 | 2006-07-20 | Sugen, Inc., South San Francisco | Phosphatmimetika und Verfahren zur Behandlung mit Phosphataseinhibitoren HIBITOREN |
| US7951829B2 (en) | 2006-05-03 | 2011-05-31 | Janssen Pharmaceutica Nv | Benzimidazole modulators of VR1 |
| CN102906074A (zh) * | 2010-05-24 | 2013-01-30 | 东亚荣养株式会社 | 稠合咪唑衍生物 |
| WO2012027965A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| CN102060780B (zh) | 2010-12-27 | 2014-11-05 | 雅本化学股份有限公司 | 2-(n-取代)-氨基苯并咪唑衍生物的制备方法 |
| WO2013029338A1 (en) | 2011-09-01 | 2013-03-07 | Glaxo Group Limited | Novel compounds |
| US9550737B2 (en) * | 2012-06-11 | 2017-01-24 | Ucb Biopharma Sprl | TNF -α modulating benzimidazoles |
| EP3089963A1 (en) | 2013-10-30 | 2016-11-09 | Novartis AG | 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof |
| KR102410076B1 (ko) | 2014-04-14 | 2022-06-22 | 베링거 인겔하임 인터내셔날 게엠베하 | Ror 감마의 조절제로서의 화합물 |
| US9718817B2 (en) | 2014-04-16 | 2017-08-01 | Glenmark Pharmaceuticals S.A. | Aryl and heteroaryl ether compounds as ROR gamma modulators |
| WO2015196335A1 (en) * | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
| US20160024052A1 (en) * | 2014-07-25 | 2016-01-28 | Innov17 Llc | Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof |
| FR3030516B1 (fr) * | 2014-12-19 | 2019-12-27 | Galderma Research & Development | Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t) |
| TW202220968A (zh) * | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| MY208400A (en) * | 2018-05-03 | 2025-05-07 | Shanghai hengrui pharmaceutical co ltd | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (ror) and pharmaceutical uses thereof |
-
2019
- 2019-05-03 MY MYPI2020005364A patent/MY208400A/en unknown
- 2019-05-03 ES ES19796430T patent/ES2949366T3/es active Active
- 2019-05-03 UA UAA202007544A patent/UA128161C2/uk unknown
- 2019-05-03 EP EP19796430.7A patent/EP3781161B1/en active Active
- 2019-05-03 SM SM20230212T patent/SMT202300212T1/it unknown
- 2019-05-03 CN CN202310017171.4A patent/CN116514722A/zh active Pending
- 2019-05-03 BR BR112020021967-3A patent/BR112020021967A2/pt unknown
- 2019-05-03 CN CN201980027956.1A patent/CN112135611B/zh active Active
- 2019-05-03 AU AU2019262169A patent/AU2019262169B2/en active Active
- 2019-05-03 CA CA3097519A patent/CA3097519A1/en active Pending
- 2019-05-03 HR HRP20230643TT patent/HRP20230643T1/hr unknown
- 2019-05-03 RS RS20230505A patent/RS64348B1/sr unknown
- 2019-05-03 WO PCT/US2019/030526 patent/WO2019213470A1/en not_active Ceased
- 2019-05-03 HU HUE19796430A patent/HUE062273T2/hu unknown
- 2019-05-03 JP JP2020560186A patent/JP7351851B2/ja active Active
- 2019-05-03 MX MX2020011405A patent/MX2020011405A/es unknown
- 2019-05-03 KR KR1020207032236A patent/KR102709804B1/ko active Active
- 2019-05-03 TW TW108115438A patent/TWI818985B/zh active
- 2019-05-03 US US17/052,451 patent/US11512055B2/en active Active
- 2019-05-03 PL PL19796430.7T patent/PL3781161T3/pl unknown
-
2022
- 2022-11-21 US US18/057,537 patent/US12187684B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522262A5 (https=) | ||
| JP2010539166A5 (https=) | ||
| HRP20240994T1 (hr) | Spoj inhibitora jak i njegova uporaba | |
| JP2019031560A5 (https=) | ||
| RU2011121876A (ru) | Пиразолопиримидиновые соединения-ингибиторы jak и способы | |
| KR102346508B1 (ko) | 키나제 억제제로서 유용한 치환된 테트라히드로카르바졸 및 카르바졸 카르복스아미드 화합물 | |
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| RU2015149767A (ru) | Дейтерированные диаминопиримидиновые соединения и фармацевтические композиции, содержащие такие соединения | |
| JP2011527667A5 (https=) | ||
| KR102345381B1 (ko) | 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물 | |
| KR102519536B1 (ko) | 트리시클릭 회전장애이성질체 화합물 | |
| JP2016527238A5 (https=) | ||
| JP2017515844A5 (https=) | ||
| JP2017504576A5 (https=) | ||
| JP2016028076A5 (https=) | ||
| JP2017508733A5 (https=) | ||
| JP2016505058A5 (https=) | ||
| JP2018526410A5 (https=) | ||
| JP2017506666A5 (https=) | ||
| JP2006507355A5 (https=) | ||
| CA3002801A1 (en) | Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors | |
| JP2017528474A (ja) | Ｐ２ｘ７調節因子 | |
| JP2006519868A5 (https=) | ||
| JP2011526911A (ja) | ベンゾイミダゾール−２−イルピリミジン誘導体を製造する方法 | |
| JP2013525490A5 (https=) |